Join the club for FREE to access the whole archive and other member benefits.

Genome Protection

Company developing and commercializing drugs for anti-aging applications capable of prolonging human health and life-span.

We are a longevity biotech company. Our founders and scientists have dedicated their lives to studying the genome and its role in aging and cancer. We believe that aging is a disease and thus can be treated. Our goal is to develop such treatments to significantly prolong healthy lifespan and protect against the many diseases of aging. Genome protection is our primary area of expertise. The human genome entombs ancient viruses called retroelements that, when awakened, propagate and wreak havoc on our cells. We aim to develop drugs that protect against cancer and age-related diseases by neutralizing the various retroelements that we collectively call the 'retrobiome'.

Visit website:


Details last updated 17-Feb-2021

Genome Protection News

Super summary of 3rd Annual Longevity Therapeutics Summit (LEAF) - 16-Feb-2021

More and more companies making greater and greater progress - 2021 could be an exciting year

Topics mentioned on this page:
Longevity Genes, Laboratory Automation